Premium
Ohio Appalachian women's perceptions of the cost of cervical cancer screening
Author(s) -
McAlearney Ann Scheck,
Song Paula H.,
Rhoda Dale A.,
Tatum Cathy,
Lemeshow Stanley,
Ruffin Mack,
Harrop J. Phil,
Paskett Electra D.
Publication year - 2010
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.25491
Subject(s) - medicine , appalachia , cervical cancer , papanicolaou stain , family medicine , pap test , cancer screening , test (biology) , cost effectiveness , incidence (geometry) , observational study , cancer , gynecology , cervical cancer screening , pathology , paleontology , risk analysis (engineering) , physics , optics , biology
BACKGROUND: Despite evidence of the importance of cervical cancer screening, screening rates in the United States remain below national prevention goals. Women in the Appalachia Ohio region have higher cervical cancer incidence and mortality rates along with lower cancer screening rates. This study explored the expectations of Appalachian Ohio women with regard to Papanicolaou (Pap) test cost and perceptions of cost as a barrier to screening. METHODS: Face‐to‐face interviews were conducted with 571 women who were part of a multilevel, observational community‐based research program in Appalachia Ohio. Eligible women were identified through 14 participating health clinics and asked questions regarding Pap test cost and perceptions of cost as a barrier to screening. Estimates of medical costs were compared with actual costs reported by clinics. RESULTS: When asked about how much a Pap test would cost, 80% of the women reported they did not know. Among women who reportedly believed they knew the cost, 40% overestimated test cost. Women who noted cost as a barrier were twice as likely to not receive a test within screening guidelines as those who did not perceive a cost barrier. Furthermore, uninsured women were more than 8.5 times as likely to note cost as a barrier than women with private insurance. CONCLUSIONS: Although underserved women in need of cancer screening commonly report cost as a barrier, the findings of the current study suggest that women may have a very limited and often inaccurate understanding concerning Pap test cost. Providing women with this information may help reduce the impact of this barrier to screening. Cancer 2010. © 2010 American Cancer Society.